We next tested for parallelism of recombinant Tau 441 in artificial CSF with endogenous tau in Alzheimer’s Disease CSF for 6 out of the 7 peptides that were detected in the two AD CSF samples (Fig 2). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.